Advances in New Modalities: New Modalities & Technologies | AIChE

Advances in New Modalities: New Modalities & Technologies


Diwan, M., Abbvie Inc.


Zhu, X., Amgen Inc
Podaralla, S., Food and Drug Administration
Gu, Q., Carnegie Mellon University

This track welcomes papers addressing the latest advances in the fundamental and applied studies of product and process development of both established and emerging novel pharmaceutical modalities. Examples include biologics and other large molecules, oligos, peptides, ADCs, gene therapy, and other new modalities in pharmaceuticals. Scientists and engineers involved in upstream and downstream development, processing, scale-up and transfer of these products are invited. Topics may include, but not limited to, cell culture preparation/fermentation, separation/purification, formulation/buffer exchange, fill/finish, and finished device/delivery. Presentations in this Advances in New Modalities: New Modalities & Technologies session will focus on novel therapeutic modalities, delivery strategies, or technologies related to therapeutic molecules.



Paper abstracts are public but to access Extended Abstracts, you must first purchase the conference proceedings.


Do you already own this?



AIChE Pro Members $150.00
AIChE Emeritus Members $105.00
AIChE Graduate Student Members Free
AIChE Undergraduate Student Members Free
AIChE Explorer Members $225.00
Non-Members $225.00